Subscribe to Newsletter

Profession

Business & Regulation Business Practice

The Challenges and Successes of A Biotech Startup

| Dan Williams | 3 min read

Discussing the challenges facing small rare disease-focussed biotechs, and the successes of advancing treatments.

Business & Regulation Profession

Life Through A Scientific Lens

| 6 min read

From academia in Milan to professional development in the UK, Valo Therapeutics CEO Marcella Origgi shares her journey.

Discovery & Development Drug Discovery

Eli Lilly and Purdue Expand Partnership with $250 Million Investment

| Rob Coker | 2 min read

Eli Lilly and Purdue University strengthen their ongoing drug discovery collaboration with further initiatives.

Business & Regulation Bioprocessing - Upstream & Downstream

The Power List Personified: Getting to Know Beatrice Lavery

| Rob Coker | 4 min read

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

Business & Regulation Profession

Denmark and Sweden Invite Misplaced US Scientists to the EU

| Rob Coker | 2 min read

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.

Business & Regulation Profession

Starting a Business in CRISPR

| Stephanie Vine | 8 min read

From a love of history books to a love of CRISPR, Monika Paule tells us the story of her career and the origins of Caszyme.

Manufacture Advanced Medicine

Kite, CAR Ts, and Access for Patients

| Stephanie Vine | 9 min read

We sat down with Kite’s Cindy Perettie to talk about access to CAR Ts.

Business & Regulation Profession

Medicine Making Pioneers

| Stephanie Vine

From Carl June to Peter Marks to Kiran Mazumdar-Shaw; check out our thought provoking interviews with some of the biggest names in the pharma field.

Business & Regulation Profession

From Benchtop Chemist to CEO

| Stephanie Vine | 5 min read

Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.

Discovery & Development Drug Discovery

Rewards in the Real World: Sitting Down With Igor Fisch

| 4 min read

Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker